{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:39:17Z","timestamp":1783118357222,"version":"3.54.6"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.autrev.2020.102739","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T02:50:04Z","timestamp":1608000604000},"page":"102739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus"],"prefix":"10.1016","volume":"20","author":[{"given":"Mart\u00edn","family":"Valdez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Aguirre-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Iv\u00e1n","family":"Vald\u00e9s-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"Mart\u00ednez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barrera-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Merayo-Chalico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102739_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2018.12.004","article-title":"Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus","volume":"18","author":"Duarte-Delgado","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00028","article-title":"Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration","volume":"9","author":"Sankowski","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.autrev.2020.102739_bb0015","series-title":"On diseases of the skin including the exanthemata","volume":"vol. IV","author":"Hebra","year":"1875"},{"key":"10.1016\/j.autrev.2020.102739_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.autrev.2005.01.008","article-title":"Neuropsychiatric features of systemic lupus erythematosus","volume":"4","author":"Borchers","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","volume":"54","author":"Bortoluzzi","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2020.102739_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.1780170212","article-title":"Preliminary criteria for the classification of systemic lupus erythematosus (SLE) evaluation in early diagnosed SLE and rheumatoid arthritis","volume":"17","author":"Trimble","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1191\/0961203304lu2024oa","article-title":"ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables","volume":"13","author":"Hanly","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0055","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0065","first-page":"101","article-title":"Seizures in patients with systemic lupus erythematosus","volume":"72","author":"Rezgui","year":"2017","journal-title":"Rev Med Liege"},{"key":"10.1016\/j.autrev.2020.102739_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"56","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0075","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","article-title":"Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study","volume":"34","author":"Ainiala","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102739_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1552-6569.2007.00183.x","article-title":"Cerebral changes in SLE with or without antiphospholipid syndrome. A case-control MRI study","volume":"18","author":"Vald\u00e9s-Ferrer","year":"2008","journal-title":"J Neuroimag"},{"key":"10.1016\/j.autrev.2020.102739_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00071","article-title":"Posterior reversible encephalopathy syndrome: clinical features and outcome","volume":"11","author":"Hinduja","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0100","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102739_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0009922810378736","article-title":"Posterior reversible encephalopathy syndrome in a 13-year-old female with mild systemic lupus erythematosus","volume":"50","author":"Golden","year":"2011","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.autrev.2020.102739_bb0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4065\/mcp.2009.0590","article-title":"Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings","volume":"85","author":"Fugate","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2020.102739_bb0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.autrev.2020.102739_bb0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clineuro.2008.11.017","article-title":"Posterior reversible encephalopathy syndrome as a complication of acute lupus activity","volume":"111","author":"Baizabal-Carvallo","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2020.102739_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12213","article-title":"Discharge status and in-hospital mortality in posterior reversible encephalopathy syndrome","volume":"130","author":"Liman","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.autrev.2020.102739_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","article-title":"The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study","volume":"259","author":"Liman","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0135","article-title":"Rheumatic diseases associated with posterior reversible encephalopathy syndrome","author":"Manadan","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102739_bb0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0961203307078682","article-title":"Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE?","volume":"16","author":"Ishimori","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WCO.0000000000000640","article-title":"Posterior reversible encephalopathy syndrome","volume":"32","author":"Liman","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","article-title":"Clinical description of seizures in patients with systemic lupus erythematosus","volume":"59","author":"Gonz\u00e1lez-Duarte","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044534","article-title":"Determinants of recovery from severe posterior reversible encephalopathy syndrome","volume":"7","author":"Legriel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102739_bb0160","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clineuro.2010.07.023","article-title":"Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors","volume":"112","author":"Burnett","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2020.102739_bb0165","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.010","article-title":"Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome","volume":"21","author":"Li","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jnnp-2014-310145","article-title":"Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study","volume":"87","author":"Merayo-Chalico","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2020.102739_bb0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.60.5.534","article-title":"Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis","volume":"60","author":"Primavera","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1552-6569.2004.tb00223.x","article-title":"Neuroimaging in posterior reversible encephalopathy syndrome","volume":"14","author":"Lamy","year":"2004","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.autrev.2020.102739_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.7461\/jcen.2013.15.3.206","article-title":"Clinical and radiological spectrum of posterior reversible encephalopathy syndrome","volume":"15","author":"Yoon","year":"2013","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"10.1016\/j.autrev.2020.102739_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00062-014-0293-7","article-title":"Posterior reversible encephalopathy syndrome: the spectrum of MR imaging patterns","volume":"25","author":"Kastrup","year":"2015","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0195","article-title":"Clinical and MRI features of posterior reversible encephalopathy syndrome with atypical regions: a descriptive study with a large sample size","volume":"11","author":"Li","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00964","article-title":"Imaging of atypical and complicated posterior reversible encephalopathy syndrome","volume":"10","author":"Saad","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3174\/ajnr.A0839","article-title":"Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10067-017-3892-2","article-title":"Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study","volume":"37","author":"Damrongpipatkul","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102739_bb0215","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0031-1277990","article-title":"Posterior reversible encephalopathy syndrome: a review","volume":"31","author":"Feske","year":"2011","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/practneurol-2011-000010","article-title":"The posterior reversible encephalopathy syndrome: What\u2019s certain, what\u2019s new?","volume":"11","author":"Roth","year":"2011","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0225","first-page":"31","article-title":"Understanding posterior reversible encephalopathy syndrome","volume":"31","author":"Fittro","year":"2018","journal-title":"J Am Acad Physician Assist"},{"key":"10.1016\/j.autrev.2020.102739_bb0230","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","article-title":"Posterior reversible encephalopathy syndrome\u2014insight into pathogenesis, clinical variants and treatment approaches","volume":"14","author":"Granata","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.2009.189647","article-title":"Posterior reversible encephalopathy syndrome: long-term follow-up","volume":"81","author":"Roth","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2020.102739_bb0240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00234-009-0504-0","article-title":"Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?","volume":"51","author":"Mueller-Mang","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.autrev.2020.102739_bb0245","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3174\/ajnr.A1588","article-title":"Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features","volume":"30","author":"Hefzy","year":"2009","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0250","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0284185113491252","article-title":"Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?","volume":"54","author":"Moon","year":"2013","journal-title":"Acta Radiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0255","first-page":"205","article-title":"Clinical spectrum of reversible posterior leukoencephalopathy syndrome","volume":"65","author":"Lee","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0260","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2214\/AJR.07.2024","article-title":"Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings","volume":"189","author":"McKinney","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.autrev.2020.102739_bb0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(54)91821-8","article-title":"The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat","volume":"264","author":"Byrom","year":"1954","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102739_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01211","article-title":"Blood\u2013brain barrier disruption as a potential target for therapy in posterior reversible encephalopathy syndrome: evidence from multimodal MRI in rats","volume":"10","author":"Wang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/01.RES.39.1.33","article-title":"Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood brain barrier","volume":"39","author":"MacKenzie","year":"1976","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2020.102739_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00696568","article-title":"Ultrastructural studies on cerebrovascular permeability in acute hypertension","volume":"32","author":"Hansson","year":"1975","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2020.102739_bb0285","first-page":"859","article-title":"Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis","volume":"19","author":"Schwartz","year":"1998","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0290","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(76)90356-5","article-title":"Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study","volume":"115","author":"Edvinsson","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2020.102739_bb0300","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.03.011","article-title":"Blood pressure fluctuations in posterior reversible encephalopathy syndrome","volume":"21","author":"Rabinstein","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0305","first-page":"2179","article-title":"Posterior reversible encephalopathy syndrome in infection, sepsis, and shock","volume":"27","author":"Bartynski","year":"2006","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0310","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0315","article-title":"Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells","volume":"285","author":"Lum","year":"2003","journal-title":"Am J Physiol"},{"key":"10.1016\/j.autrev.2020.102739_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0773.2003.920104.x","article-title":"Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats","volume":"92","author":"Narushima","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.autrev.2020.102739_bb0325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainresbull.2017.03.012","article-title":"Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome","volume":"131","author":"Chen","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.autrev.2020.102739_bb0330","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.1988.109","article-title":"Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema","volume":"8","author":"Wahl","year":"1988","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.autrev.2020.102739_bb0335","first-page":"934","article-title":"Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion","volume":"79","author":"Mastorakos","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2020.102739_bb0340","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/acr.22047","article-title":"Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus","volume":"65","author":"Lai","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2020.102739_bb0345","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0961203307085405","article-title":"Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature","volume":"17","author":"Leroux","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0350","first-page":"2178","article-title":"Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus","volume":"33","author":"Kur","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2020.102739_bb0355","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0360","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semarthrit.2006.01.002","article-title":"Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus","volume":"35","author":"Magnano","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0365","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/acr.22047","article-title":"Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus","volume":"65","author":"Lai","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2020.102739_bb0370","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s10067-015-3055-2","article-title":"The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus","volume":"34","author":"Budhoo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102739_bb0375","first-page":"12","article-title":"Posterior reversible encephalopathy syndrome could be an underestimated variant of \u201creversible neurological deficits\u201d in Systemic Lupus Erythematosus","author":"Liu","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0380","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clinimag.2017.08.008","article-title":"The imaging spectrum of posterior reversible encephalopathy syndrome: a pictorial review","volume":"47","author":"Brady","year":"2018","journal-title":"Clin Imag"},{"key":"10.1016\/j.autrev.2020.102739_bb0385","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/0961203319856416","article-title":"Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study","volume":"28","author":"Cui","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0390","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/0961203313496341","article-title":"Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome","volume":"22","author":"Jung","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0395","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.semarthrit.2011.07.001","article-title":"Posterior reversible encephalopathy syndrome: an emerging disease manifestation in systemic lupus erythematosus","volume":"41","author":"Barber","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0961203309345749","article-title":"Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations?","volume":"19","author":"Bag","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0405","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1189\/jlb.3RU0816-352RR","article-title":"Endothelial cell activation in central nervous system inflammation","volume":"101","author":"Wu","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2020.102739_bb0410","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2020.102739_bb0415","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2017.04.008","article-title":"The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface","volume":"16","author":"Stock","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cei.13095","article-title":"Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome","volume":"192","author":"Merayo-Chalico","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102739_bb0425","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1191\/0961203303lu501oa","article-title":"The blood-brain barrier in systemic lupus erythematosus","volume":"12","author":"Abbott","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102739_bb0430","first-page":"1819","article-title":"ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro","volume":"148","author":"Steffen","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2020.102739_bb0435","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2020.102739_bb0440","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0445","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.humimm.2016.06.016","article-title":"Lymphopenia and autoimmunity: a double-edged sword","volume":"77","author":"Merayo-Chalico","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2020.102739_bb0450","first-page":"542","article-title":"Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort","volume":"5","author":"Danila","year":"2009","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.autrev.2020.102739_bb0455","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1002\/art.27700","article-title":"Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease","volume":"62","author":"Sato","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102739_bb0460","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psyneuen.2007.12.007","article-title":"Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus","volume":"33","author":"Nishimura","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.autrev.2020.102739_bb0465","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2005.048330","article-title":"Raised serum S100B protein levels in neuropsychiatric lupus","volume":"65","author":"Schenatto","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102739_bb0470","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102739_bb0475","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/WCO.0000000000000809","article-title":"Persistent inflammatory states and their implications in brain disease","volume":"33","author":"Vald\u00e9s-Ferre","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.autrev.2020.102739_bb0480","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","article-title":"Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier","volume":"91","author":"Gelb","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102739_bb0485","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"Degiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102739_bb0490","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0495","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1212\/WNL.0b013e3181dad590","article-title":"Antibodies in patients with neuropsychiatric systemic lupus erythematosus","volume":"74","author":"Kimura","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2020.102739_bb0500","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.autrev.2007.02.007","article-title":"Psychiatric manifestations in systemic lupus erythematosus","volume":"6","author":"Stojanovich","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102739_bb0505","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00004728-198306000-00015","article-title":"Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus","volume":"7","author":"Vermess","year":"1983","journal-title":"J Comput Assist Tomogr"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220303207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:19:45Z","timestamp":1761599985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220303207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1568997220303207"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102739","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102739"}}